Miami-based Opko Health has just taken over Israel’s Prolor Biotech. Prolor develops long-lasting medicines including a human growth hormone, a clotting factor for hemophilia and treatments for diabetes and obesity. The CEO of Opko is also the Chairman of Israel’s Teva.
http://www.globes.co.il/serveen/globes/docview.asp?did=1000838565&fid=1725
Israeli biotech goes to USA for $480 million
This entry was posted in Economy & Business. Bookmark the permalink.